Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients

NCT04747275 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Transitioned to multi site study with sponsor

Conditions

Hypothyroidism
Trisomy 21

Interventions

DRUG: Liquid stable levothyroxine (L-T4) Tirosint-SOL
DRUG: Oral tablet levothyroxine (L-T4)

Sponsor

Children's Mercy Hospital Kansas City